Neither fixed nor random: weighted least squares meta-regression
- PMID: 27322495
- DOI: 10.1002/jrsm.1211
Neither fixed nor random: weighted least squares meta-regression
Abstract
Our study revisits and challenges two core conventional meta-regression estimators: the prevalent use of 'mixed-effects' or random-effects meta-regression analysis and the correction of standard errors that defines fixed-effects meta-regression analysis (FE-MRA). We show how and explain why an unrestricted weighted least squares MRA (WLS-MRA) estimator is superior to conventional random-effects (or mixed-effects) meta-regression when there is publication (or small-sample) bias that is as good as FE-MRA in all cases and better than fixed effects in most practical applications. Simulations and statistical theory show that WLS-MRA provides satisfactory estimates of meta-regression coefficients that are practically equivalent to mixed effects or random effects when there is no publication bias. When there is publication selection bias, WLS-MRA always has smaller bias than mixed effects or random effects. In practical applications, an unrestricted WLS meta-regression is likely to give practically equivalent or superior estimates to fixed-effects, random-effects, and mixed-effects meta-regression approaches. However, random-effects meta-regression remains viable and perhaps somewhat preferable if selection for statistical significance (publication bias) can be ruled out and when random, additive normal heterogeneity is known to directly affect the 'true' regression coefficient. Copyright © 2016 John Wiley & Sons, Ltd.
Keywords: fixed effect; meta-regression; random effects; weighted least squares.
Copyright © 2016 John Wiley & Sons, Ltd.
Comment in
-
Heterogeneity: multiplicative, additive or both?Res Synth Methods. 2017 Mar;8(1):119-120. doi: 10.1002/jrsm.1223. Epub 2016 Oct 17. Res Synth Methods. 2017. PMID: 27749989 No abstract available.
Similar articles
-
Neither fixed nor random: weighted least squares meta-analysis.Stat Med. 2015 Jun 15;34(13):2116-27. doi: 10.1002/sim.6481. Epub 2015 Mar 23. Stat Med. 2015. PMID: 25809462
-
Finding the power to reduce publication bias.Stat Med. 2017 May 10;36(10):1580-1598. doi: 10.1002/sim.7228. Epub 2017 Jan 27. Stat Med. 2017. PMID: 28127782
-
Meta-regression approximations to reduce publication selection bias.Res Synth Methods. 2014 Mar;5(1):60-78. doi: 10.1002/jrsm.1095. Epub 2013 Sep 3. Res Synth Methods. 2014. PMID: 26054026
-
Random-effects models for meta-analytic structural equation modeling: review, issues, and illustrations.Res Synth Methods. 2016 Jun;7(2):140-55. doi: 10.1002/jrsm.1166. Res Synth Methods. 2016. PMID: 27286900 Review.
-
Large trials vs meta-analysis of smaller trials: how do their results compare?JAMA. 1996 Oct 23-30;276(16):1332-8. JAMA. 1996. PMID: 8861993 Review.
Cited by
-
Approaches for combining primary care electronic health record data from multiple sources: a systematic review of observational studies.BMJ Open. 2020 Oct 14;10(10):e037405. doi: 10.1136/bmjopen-2020-037405. BMJ Open. 2020. PMID: 33055114 Free PMC article.
-
A new justification of the Hartung-Knapp method for random-effects meta-analysis based on weighted least squares regression.Res Synth Methods. 2019 Dec;10(4):515-527. doi: 10.1002/jrsm.1356. Epub 2019 Aug 14. Res Synth Methods. 2019. PMID: 31111673 Free PMC article.
-
Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis.JNCI Cancer Spectr. 2019 May 11;3(2):pkz033. doi: 10.1093/jncics/pkz033. eCollection 2019 Jun. JNCI Cancer Spectr. 2019. PMID: 31360906 Free PMC article.
-
Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysis.Ther Adv Med Oncol. 2020 Apr 27;12:1758835920915299. doi: 10.1177/1758835920915299. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32426044 Free PMC article. Review.
-
Continuing Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Advanced Breast Cancer: A Meta-Analysis.Cancers (Basel). 2025 May 9;17(10):1609. doi: 10.3390/cancers17101609. Cancers (Basel). 2025. PMID: 40427107 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources